Card image cap

James Lankford's Public Statements on Issue: Science

Office:

Current Issue:

Science

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Date Title
10/19/2021 Blackburn, Marshall, Colleagues Introduce Legislation To Halt Viral Gain Of Function Research
10/19/2021 Lankford, Marshall to Stop Dangerous Viral Research by Foreign Entities
09/22/2021 Letter to Merrick Garland, Attorney General, Xavier Becerra, Secretary of Health and Human Services, Francis Collins, Director of National Institute of Health - Sens. Cruz, Hawley, Reps. McClain, Luetkemeyer Send Letter to DOJ on Fetal Tissue Research
09/01/2021 Letter to the Hon. Charles Schumer, the Hon. Mitch McConnell, the Hon. Nancy Pelosi, and the Hon. Kevin McCarthy - Incorporate EPSCoR Provisions in the Conference Bill
05/27/2021 Senators Braun, Daines, Lankford's amendment to outlaw animal-human hybrids receives vote on Senate floor
05/27/2021 Lankford, Braun, Daines Push to Outlaw Animal-human Hybrids
04/21/2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, and the Hon. Charles Schumer, Senate Minority Leader - Gaetz, McSally Urge House, Senate Leadership to Prevent Funding of Dangerous Wuhan Laboratory
07/31/2019 Senators Introduce Pro-Life Legislation to Save Human Embryos
11/29/2018 Executive Session
06/18/2018 Letter to the Honorable Allison C. Lerner, Inspector General for the National Science Foundation - National Science Foundation
11/02/2017 Congressmen Norman & Gosar Introduce Regulatory Improvement Bill
03/09/2017 Hearing of the Regulatory Affairs and Federal Management Subcommittee of the Senate Homeland Security and Governmental Affairs Committee - Opening Statement of Sen. Lankford, Hearing on Agency Use of Science in the Rulemaking Process: Proposals for Improving Transparency and Accountability
04/15/2016 Letter to Dr. Janet Woodcock, M.D. Director, CDER, U.S. Food and Drug Administration - Urging FDA to Advance Muscular Dystrophy Therapies
arrow_upward